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ABSTRACT
Despite many methodological advances that have fa-
cilitated investigation of Mycobacterium tuberculo-
sis pathogenesis, analysis of essential gene func-
tion in this slow-growing pathogen remains diffi-
cult. Here, we describe an optimized CRISPR-based
method to inhibit expression of essential genes
based on the inducible expression of an enzymat-
ically inactive Cas9 protein together with gene-
specific guide RNAs (CRISPR interference). Using
this system to target several essential genes of M.
tuberculosis, we achieved marked inhibition of gene
expression resulting in growth inhibition, changes in
susceptibility to small molecule inhibitors and dis-
ruption of normal cell morphology. Analysis of ex-
pression of genes containing sequences similar to
those targeted by individual guide RNAs did not
reveal significant off-target effects. Advantages of
this approach include the ability to compare inhib-
ited gene expression to native levels of expression,
lack of the need to alter the M. tuberculosis chro-
mosome, the potential to titrate the extent of tran-
scription inhibition, and the ability to avoid off-target
effects. Based on the consistent inhibition of tran-
scription and the simple cloning strategy described
in this work, CRISPR interference provides an effi-
cient approach to investigate essential gene func-
tion that may be particularly useful in characterizing
genes of unknown function and potential targets for
novel small molecule inhibitors.
INTRODUCTION
CRISPR-Cas9 based methods for gene editing in eu-
karyotic cells have advanced rapidly since the first func-
tional and mechanistic insights into this programmable
endonuclease-mediated bacterial immunity system (1–3).
Though CRISPR biotechnology derives from bacterial
systems for degrading foreign DNA, the development of
CRISPR-based systems for genome editing and control
of gene expression in bacteria has been relatively limited
(1,4,5).
In mycobacteria, several well-developed methods allow
for deletion of non-essential genes (6–9). The study of essen-
tial genes, which comprise approximately 20% of the My-
cobacterium tuberculosis genome and which encode the pro-
teins targeted by all current anti-tuberculars, has been more
challenging. Protein depletion systems have been used, but
these require the addition of tag-encoding sequences to the
3′ end of coding sequences in the M. tuberculosis chromo-
some (10,11). In addition to the time required to add the
sequences encoding these tags to genes of interest, these in-
sertions may alter the expression of downstream genes in
the same operon as the targeted gene and the tag may in-
terfere with the function of the protein, even in the absence
of degradation of the targeted protein. Further, substantial
variation in the extent of depletion has been observed with
degradation-tag protein depletion systems (10).
An alternative approach, genetic depletion has also been
used with some success, with regulated expression of the
gene of interest from an inducible promoter in a strain in
which native expression has been abrogated, typically by
deletion. This approach, however, requires construction of
a merodiploid strain. A major limitation of this approach is
that achieving physiologic levels of the desired mRNA can
be challenging with the inducible promoter systems avail-
able for use inM. tuberculosis (12–14).
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CRISPR interference (CRISPRi) (15) has the potential
to overcome some of these limitations to allow more facile
analysis of essential genes inM. tuberculosis. This approach
incorporates expression of a small guide RNA (sgRNA) to
target the gene of interest in a bacterial cell in which a cat-
alytically inactive Cas9 protein (dCas9) is expressed. The
sgRNA binds specifically to the target gene via a short (12–
20 nucleotide (nt)) sequence that is homologous to a se-
quence in the gene, and recruits dCas9 to the site via the
‘handle’ sequence. The result is interferencewith either tran-
scription initiation or elongation, depending on the target
site chosen, leading to lower levels of RNA of the gene tar-
geted (15). An initial report of CRISPRi in mycobacteria
was recently published, demonstrating that this approach
can work (16). Although this report provided some data
demonstrating CRISPRi in M. tuberculosis, most of the
data characterized CRISPRi activity in the non-pathogenic
rapid growerMycobacterium smegmatis.
In this work, we describe an optimized system for
CRISPR-dCas9-mediated RNA interference inM. tubercu-
losis, including (i) a vector for expression of dCas9 at lev-
els that do not interfere with bacterial growth but are suffi-
cient to achieve consistent, physiologically relevant inhibi-
tion of gene expression, and (ii) a vector that allows sim-
ple directional cloning of annealed primers that contain the
appropriate sequence for targeting the gene of interest, and
(iii) expression of dcas9 and sgRNAs from inducible Tet re-
pressor (TetR)-regulated promoters that can be titrated to
achieve a range of inhibition of expression of target gene.
We demonstrate potent and sustained knockdown of ex-
pression of several essential M. tuberculosis genes, and the
ability to modulate the extent of transcription inhibition.
We illustrate the value of this approach in several types of
phenotypic analysis to gain insight into essential gene func-
tion inM. tuberculosis.
MATERIALS AND METHODS
Bacterial strains, culture conditions and growth curves
Bacterial strains used in this study were Escherichia coli
DH5,M. smegmatis mc2-155 andM. tuberculosis H37Rv.
Escherichia coliDH5was used for cloning and vector con-
struction and was cultured in Luria–Bertani medium sup-
plemented with antibiotics when appropriate (50 g/ml
kanamycin or 200 g/ml hygromycin). Mycobacterium
smegmatis and M. tuberculosis were cultured in Middle-
brook 7H9 broth supplemented with 0.5% albumin, 0.2%
dextrose, 0.085% NaCl, 0.2% glycerol and 0.05% Tween 80
(M-ADN-Tw), and with antibiotics when appropriate (25
g/ml kanamycin or 50 g/ml hygromycin). Mycobacteria
were grown at 37◦C with shaking at 120 rpm. For induc-
tion of sgRNA and dcas9 expression,M. smegmatis andM.
tuberculosis cultures were supplemented with anhydrotetra-
cycline (aTc) to achieve a final concentration of 200 ng/ml.
Addition of aTc was repeated every 48 h to maintain induc-
tion of dcas9 and sgRNAs for experiments that extended
beyond 48 h.
To monitor growth with and without induction of
CRISPRi, M. tuberculosis cells containing the integrated
dcas9-expressing vector plus the replicating vector express-
ing a gene-specific sgRNA or a control sequence that is not
homologous to any M. tuberculosis sequence, were inocu-
lated from log phase cultures intoM-ADN-Twmedium to a
theoretical OD600 of 0.001. Cultures were incubated at 37◦C
with shaking at 120 rpm. When the OD600 reached 0.1–0.2
the cultures were split into equal volumes and further in-
cubated with or without the addition of aTc to induce ex-
pression of dcas9 and the sgRNA. aTc was added to a final
concentration of 200 ng/ml every 48 h and cultures were
grown for 4–6 days.
Construction of vectors for regulated expression of dcas9 and
sgRNAs, and selection of sgRNA protospacer sequences
pRH2502, a vector expressing an inactive version of Strep-
tococcus pyogenes cas9, was constructed by assembling two
DNA blocks in which the cas9DNA sequence had been op-
timized for expression inM. tuberculosis (GenScript) (Sup-
plementary Figure S1). Mutations to eliminate Cas9 enzy-
matic activity (dcas9) were incorporated into this sequence
at codon 10 (Asp to Ala) and codon 820 (His to Ala). The
assembled dcas9 DNA was cloned into a mycobacterial in-
tegrating vector to obtain pRH2502, in which dcas9 is ex-
pressed from a TetR-regulated uvtetO promoter (Supple-
mentary Figure S2) (17,18).
For expression of sgRNAs, we constructed a vector in
which the sgRNA is expressed from a TetR-regulated smyc
promoter (Pmyc1tetO) (pRH2521) (18) (Supplementary Fig-
ure S2). To allow simple, directional cloning of any sequence
into this vector we used a strategy similar to that of Hwang
et al (19), by incorporating two Type IIS restriction enzyme
(BbsI) sites into these vectors. When cut by BbsI, two dif-
ferent 4 nt overhangs are generated in the vector and the
BbsI sites are eliminated (Supplementary Figure S3). To ex-
press sgRNAs that target specific genes in M. tuberculosis,
two complementary oligonucleotides containing 20 bases
homologous to the target sequence plus 4 bases at the 5′
end of each oligonucleotide that are complementary to the
overhangs that result from BbsI digestion of the vectors,
were annealed, phosphorylated and cloned into the BbsI-
digested vector (Supplementary Figure S3). All oligonu-
cleotides were designed so that the expressed sgRNA con-
tains a 20 bp sequence that is complementary to the non-
template strand of the target gene. These vectors were de-
signed so that the transcription start site is the first base of
the complementary sequence. In each case the chromoso-
mal sequence that is targeted directly follows the sequence
CCX on the non-template strand, i.e. the reverse comple-
ment of the NGG protospacer adjacent motif (PAM) se-
quence. This vector also expresses a codon-optimized tetR
expressed from the mycobacterial imyc promoter (13,18).
These vectors were transformed into M. tuberculosis cells
into which pRH2502 (for dcas9 expression) had been previ-
ously introduced.
To select 20 nt sequences in genes of interest as pro-
tospacers to incorporate into sgRNAs, we first identified
PAMs (NGG) in the promoter region, 5′ untranslated re-
gion (UTR) and coding sequence of these genes. We then
searched theM. tuberculosis genome sequence to determine
whether the identified sequences were unique. The oligonu-
cleotides used to generate sgRNA constructs to target-
specific genes are shown in Supplementary Table S2.
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RNA Isolation, 5′-RACE and RT-qPCR
To identify transcription start sites (TSS) ofM. tuberculosis
genes for which the TSS was not known, we performed 5′-
rapid amplification of cDNA ends (5′-RACE) as previously
described (20). For analysis of expression of dcas9 and re-
pression of genes of interest targeted by sgRNAs, strains
were grown with or without aTc as described above. Sam-
ples fromM. tuberculosis cultures were taken every 24 h for
isolation of RNA, cells were harvested by centrifugation,
re-suspended in TRI Reagent (Molecular Resource Center)
and mechanically disrupted with 0.1 mm Zirconia beads in
a MagNA Lyser instrument (Roche) by agitating the sam-
ples 4–6 times at 7000 rpm for 45 s. RNA was extracted,
purified and treated with Turbo DNAse (Thermo Fisher)
twice (20). Quantity and quality of RNAwas determined by
measuring absorbance at 260 and 280 nmusing aNanodrop
instrument (Thermo Fisher) and the absence of significant
contaminating genomic DNA was confirmed by qPCR of
the RNA without reverse transcription.
Reverse transcription (RT) and quantitative PCR of
cDNA (RT-qPCR) were performed using the Quanta Bio-
sciences qScript cDNA synthesis kit and the PerfeCTa-
SYBR green Supermix, respectively. qPCR was performed
on an Applied Biosystems 7300 real time PCR system with
Seqeunce Detection Software version v1.4.0, as previously
described (20). The RT reaction was performed with 100
ng RNA isolated and purified as described above in a fi-
nal reaction volume of 20 l. Integrity of each RNA sam-
ple was determined using the 3’:5’ method in which qPCR
of each cDNA was performed using two primer pairs, one
of which amplifies a sequence from the 5′ end of the ref-
erence gene sigA and the other from the 3′ end of the gene
(21). All 3′:5′ ratios exceeded 0.2, consistent with intact non-
degraded RNA. Primers for RT-qPCR were designed using
NCBI primer blast online tool (http://www.ncbi.nlm.nih.
gov/tools/primer-blast) to generate amplicons of 130–150
nt (Supplementary Table S2). Amplification efficiency of all
M. tuberculosis primer pairs was determined to be >95%
based on the slope of a standard curve of serial dilutions of
cDNA. Data were analyzed using the CT method with
the M. tuberculosis reference gene sigA as the control (22).
Biological duplicate samples were analyzed for each target
sequence. Significance of the differences between the expres-
sion of uninduced versus aTc-induced cultures were deter-
mined at each time point using an unpaired t-test (Prism
5.0, GraphPad Software).
Western blotting
Mycobacterium tuberculosis broth cultures were harvested,
washed with PBS plus 0.05% Tween 80, resuspended in
TRI Reagent (Molecular Resource Center) and mechani-
cally disrupted as described above. Proteins were extracted
following the manufacturer’s protocol and solubilized in
9.5 M urea/2% CHAPS, pH 9.1 (23,24). For western blot-
ting, 10 g of protein was resolved by SDS-PAGE followed
by transfer to a PVDF membrane, which was probed with
primary rabbit polyclonal sera against PknB (1:3000) fol-
lowed by anti-rabbit secondary antibody (1:10 000) (Cell
Signaling Technology). The blot was incubated with Lu-
miGLO chemiluminescent substrate (Cell Signaling Tech-
nology) andmembrane-bound antibody was detected using
a Kodak Image Station (Carestream Health).
Antibiotic susceptibility determination
Mycobacterium tuberculosisH37Rv expressing dcas9 and ei-
ther the control sgRNA or sgRNAs targeting inhA or dfrA
were tested for drug susceptibility using theMicroplate Ala-
mar Blue Assay (MABA) (25). 100 l of 7H9 medium con-
taining 2X the desired concentration of the specific drug
(isoniazid or methotrexate) was added to wells of a 96-well
plate.M. tuberculosis strains were grown at 37◦Cwith shak-
ing (120 rpm) to an OD600 between 0.6 and 0.8 and then di-
luted to a theoretical OD600 of 0.001 inM-ADN-Tw culture
medium. 100 l of this dilutedM. tuberculosiswas added to
each well. To obtain CRISPRi-mediated repression of gene
expression aTc was added to a final concentration of 200
ng/ml every 48 h. Plates were incubated at 37◦C for 6 days,
at which point 20 l of Alamar Blue (Invitrogen) + 12.5 l
of 20% Tween 80 were added to each well. Plates were incu-
bated at 37◦C for an additional 18–24 h and then read in a
fluorescent plate reader (Ex 540 nm/Em 595 nm) (Tecan).
The IC50 was defined as the lowest drug concentration that
reduced fluorescence by 50% compared to control wells with
no inhibitor.
Microscopy
To examine effects on cell morphology resulting from
CRISPRi of select genes, cells were grown in M-ADN-Tw
medium, harvested, washed in PBS with 0.05% Tween 80,
and fixed in 4%paraformaldehyde in PBS for 2 h. Fixed cells
were pelleted, washed and resuspended in PBS plus 0.05%
Tween 80. SinceM. tuberculosis cells tend to clump together,
the cell suspension was briefly sonicated in a Bioruptor
UCD-200 sonication water bath (Diagenode, Belgium) for
10 s at medium setting. 5–10 l of the cell suspension was
spotted on a 1% agarose coated glass slide to immobilize the
cells. A coverslip was placed on the slide, and the cells were
imaged immediately. The cell morphology was visualized
using a Nikon Eclipse TE2000-E inverted microscope fitted
with a 100x Plan Achromatic phase contrast oil-immersion
objective with a 1.25 numerical aperture. Photographs were
collected with a Hamamatsu ORCA-AG CCD camera, us-
ing IPLab imaging software. Cell length and width were
measured by using ObjectJ, an ImageJ plugin, according
to instructions provided on the ObjectJ website (https://sils.
fnwi.uva.nl/bcb/objectj/). The length of the FtsZ-inhibited
branched bacteria was determined by measuring the dis-
tance between the tips of the two longest branches. The
length of the filamentous or rod-shaped cells was deter-
mined by measuring the distance between the cell poles.
Cell length and width in ftsZ+25 sgRNA containing cells
with and without aTc induction were compared using an
unpaired t-test (Prism 5.0, GraphPad Software).
RESULTS
Vectors for CRISPRi in mycobacteria
We obtained custom-synthesized DNA (GenScript) en-
coding cas9 of Streptococcus pyogenes (39.1% GC) that
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was codon-optimized for expression in M. tuberculosis
(65.6% GC) (26) (Supplementary Figure S1). Two muta-
tions, Asp10Ala and His820Ala, were incorporated into
this sequence to express a catalytically inactive dCas9 pro-
tein (15). This codon-optimized dcas9 was cloned under
control of the aTc-inducible uv15tetO promoter in an inte-
grating mycobacterial vector (17,18) (Supplementary Fig-
ure S2).
For expression of small guide RNAs (sgRNAs), se-
quences containing all but the gene-specific targeting se-
quences of the sgRNA were cloned into a mycobacterial
replicating vector that expresses a TetR protein optimized
for mycobacteria (13) in which expression of the sgRNA
was driven from the TetR-regulated Pmyc1tetO promoter
(Supplementary Figure S2) (18). To allow simple directional
cloning of any gene-targeting sequence into this vector we
used a strategy similar to that of Hwang et al. (19), in-
corporating two Type IIS restriction enzyme (BbsI) sites
into the vectors. To obtain sgRNAs that target specific se-
quences in the mycobacterial chromosome, two comple-
mentary oligonucleotides corresponding to the targeted se-
quence plus sequences complementary to the overhangs
that result from BbsI digestion of the vectors, were an-
nealed, phosphorylated and cloned into the BbsI-digested
vector. The vector is designed so that transcription of the
sgRNA starts at the first nt of the sequence homologous to
the sequence in the target gene (Supplementary Figure S3).
Testing CRISPRi inMycobacterium smegmatis
We first tested the CRISPRi vectors for their ability to in-
hibit gene expression in the rapid-growing non-pathogenic
species M. smegmatis. These initial experiments targeted
genes encoding the alternative sigma factor sigH, which reg-
ulates the expression of a large number of genes in response
to oxidative and other stresses (20,27,28), and the essential
Ser/Thr protein kinase pknB, which regulates cell shape and
cell wall synthesis (29–31). As shown in Figure 1, for both
genes we chose 3 target sequences. For sigH, which is the
first gene in its operon, these included a site in the -35 ele-
ment of the promoter, a site in the 5′-UTRbetween the tran-
scription start site and the initiation codon and a sequence
in the 5′ end of the coding sequence. For pknB, which is
the last gene in a 5-gene operon, we targeted three sites in
the coding sequence. We obtained extremely high levels of
dcas9 in the presence of the inducer aTc in each case. Us-
ing aTc-induced expression of these sgRNAs to target these
two genes we observed decreased expression, achieving up
to 60–80% knockdown. Figure 1 shows the results for the
construct that achieved the greatest depletion for each gene.
CRISPRi inM. tuberculosis
Based on these successful pilot experiments inM. smegma-
tis, we investigated this gene depletion system in depth in
the important global pathogenM. tuberculosis. We first as-
sessed the effects of expressing a sgRNA vector that did not
include a gene-specific targeting sequence. Induced and un-
induced cultures were grown and samples were taken for
measurement of growth (OD600) and for RNA isolation.
Using this construct we observed ∼20-fold induced expres-
sion of dcas9 at 8 h after addition of aTc to a final con-
centration of 200 ng/ml, followed by a steady decrease to
∼11-fold induced expression at 96 h, despite addition of a
second aliquot of aTc at 48 h (Figure 2). Importantly, there
was no difference in growth between the induced and un-
induced strains and, as expected, no decrease in pknB ex-
pression was observed with induction of the strain contain-
ing this sgRNA control vector (Figure 2).
We then examined the effect of expressing sgRNAs with
gene-specific sequences, starting with pknB, an essential
Ser/Thr protein kinase of M. tuberculosis. Because M. tu-
berculosis pknB is at the 3′ end of an operon, we targeted 3
sites in the coding sequence (Figure 2). Each sgRNA con-
struct was transformed into M. tuberculosis into which the
dcas9-expressing integrating vector had been introduced.
Expression of dcas9 and pknB were determined by RT-
qPCR at serial time points in cultures induced with 200
ng/ml aTc and in control cultures to which no inducer was
added. We observed strongly induced expression of dcas9
in these experiments, though less than we observed with
the same construct in M. smegmatis. For each sgRNA we
observed dcas9 induction of 50–60-fold relative to the un-
induced control at 8 h, decreasing to ∼10–20-fold at 96 h,
despite addition of a second aliquot of aTc at 48 h to achieve
a concentration of 200 ng/ml. For the induced strains ex-
pressing sgRNAs targeting the +51 and +143 sequences we
obtained 80–90% reduction of pknBRNA abundance com-
pared to the un-induced strains; the +8 sequence-targeting
sgRNA was slightly less effective, achieving 60–70% reduc-
tion in pknB mRNA (Figure 2). For each strain, we ob-
served slower growth of the induced CRISPRi strain start-
ing at 48–96 h. This result is similar to genetic experiments
that show decreased growth compared to wild type starting
at 3–4 days after onset of pknB depletion (31). To determine
whether this growth defect was more evident with longer in-
cubation, we performed growth curves starting at OD600 0.1
and compared growth from induced and un-induced cul-
tures expressing the +51 and +143 sgRNAs over 6 days.
We observed decreased growth in the induced strains, start-
ing between days 2 and 3, with increasing separation of
the growth curves through day 6 (Figure 2).These results
demonstrate the ability of CRISPRi to achieve substantial
inhibition of gene expression inM. tuberculosis sufficient to
cause a clear growth phenotype.
The experiments described above focused on measure-
ment of gene-specific mRNA based on the mechanism of
CRISPRi, i.e. inhibition of transcription. To verify that de-
creasedmRNA resulted in decreased protein corresponding
to the gene being targeted, we performed western blotting
using an anti-PknB antibody. As expected and consistent
with the growth defect we observed, we found that depletion
of pknB mRNA by CRIPSRi resulted in marked depletion
of PknB protein (Figure 2).
Using CRISPRi to investigate phenotypes of essentialM. tu-
berculosis genes
We expect that major uses of a CRISPRi system in M. tu-
berculosis will be to investigate essential genes of unknown
function, and to identify or verify targets of small molecule
inhibitors of growth identified in whole cell screens. To de-
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Figure 1. CRISPRi of sigH and pknB in M. smegmatis. (A) Position of target sequences, shown by purple vertical lines. Numbering refers to the first
nucleotide in the target sequence relative to annotated start of coding sequence. Circled sgRNAs are those for which expression data are shown. The arrow
shows the position of the transcription start site. (B and D) Expression of dcas9 determined by RT-qPCR with and without induction of dcas9 and the
sgRNA indicated. (C and E) Expression of pknB and sigH, respectively, with and without induction. The significance of the difference in gene-specific
RNA between samples from induced and uninduced cultures is indicated by asterisks above the bar for the induced sample (*P< 0.01; **P< 0.001; ***P
< 0.0001).
termine the utility of this system for these purposes, we
selected four additional essential genes to test. Two (inhA
(Rv1484) and dfrA (Rv2763c)) are the targets of the small
molecule drugs isoniazid and methotrexate, respectively,
and two others (wag31 (Rv2145c) and ftsZ (Rv2150c)) have
both growth and morphologic phenotypes when they are
genetically depleted inM. smegmatis (32–35). Only for ftsZ
had the transcriptional start sites (TSSs) been previously de-
termined experimentally (36). We therefore determined the
TSS for inhA, dfrA and wag31 using 5′-RACE as previously
described (Supplementary Figure S4) (20). We then de-
signed 3 sgRNA-expressing constructs for each gene, based
on the location of PAM sequences in the promoter, 5′-UTR
and coding sequences (Supplementary Figure S4). As de-
scribed above, these vectorswere transformed intoM. tuber-
culosis containing the integrating vector expressing dcas9
and effects on gene expression and growth, with and with-
out induction were determined. Samples were obtained at
24 and 48 h tomeasure gene-specificmRNAandOD600 was
measured every 24 h from 0 to 96 h. In each case, we ob-
served induction of dcas9 at 24 and 48 h, ranging from ap-
proximately 20-fold up to 65-fold relative to the uninduced
level (Figures 3 and 4). For each construct, fold induction
of dcas9 was stable between 24 and 48 h.
For both inhA and dfrA, two of three sgRNAs achieved
80–90% knockdown of specific mRNA at 24 and 48h fol-
lowing induction (Figure 3) while the third sgRNAachieved
10–50% inhibition (data not shown). For both genes, the
twomost effective RNAdepletion constructs resulted in de-
creased growth starting at 48–72 h following induction. We
also determined whether the depletion of these RNAs re-
sulted in increased susceptibility to chemical inhibitors, as
would be expected from depletion of InhA or DhfR pro-
teins. Using the MABA (25), we determined that the IC50
of isoniazid for the strains expressing both sgRNAs that
decreased inhA transcript abundance was 4-fold lower (0.01
g/ml) than the IC50 of isoniazid for wild type (0.04g/ml)
(Figure 3 and Supplementary Figure S5).
Similar results were obtained with two sgRNAs that op-
timally inhibited transcription of dfrA. Specific transcript
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Figure 2. CRISPRi of pknB inM. tuberculosis at serial time points. (A) Position of target sequences, shown by purple vertical lines. Numbering refers to
the first nucleotide in the target sequence relative to the annotated start of the pknB coding sequence. (B, E, H, K) Expression of dcas9 with and without
induction of dcas9 and the sgRNA indicated. (C, F, I, L) Expression of pknB with and without induction of dcas9 and the sgRNA indicated. (D, G, J,
M) Growth curves of culture with and without induction of dcas9 and the sgRNA indicated. (N, O) Extended growth curves. (P) Immunoblot of total
protein from the last two time points shown in panel (O) using rabbit polyclonal anti-PknB antibody. VC, vector control. The significance of the difference
in gene-specific RNA between samples from induced and uninduced cultures is indicated by asterisks above the bar for the induced sample (*P < 0.01;
**P < 0.001; ***P < 0.0001).
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Figure 3. CRISPRi of inhA and dfrA inM. tuberculosis. (A, D, G, J) Expression of dcas9 with and without induction of dcas9 and the sgRNA indicated.
(B, E, H, K) Expression of inhA or dfrA with and without induction of dcas9 and the sgRNA indicated. (C, F, I, L) Growth curves of culture with and
without induction of dcas9 and the sgRNA indicated. (M, N) Inhibition of fluorescence in the MABA at different concentrations of methotrexate (M)
or isoniazid (N) with induction of the sgRNAs indicated, compared to vector control. The significance of the difference in gene-specific RNA between
samples from induced and uninduced cultures is indicated by asterisks above the bar for the induced sample (*P < 0.01; **P < 0.001; ***P < 0.0001).
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abundance was reduced by 80–90% in both strains when
the sgRNA was induced and a growth defect was observed
(Figure 3). In the MABA assay, induction of both sgRNAs
targeting dfrA led to increased susceptibility to the dihydro-
folate reductase inhibitor methotrexate. The methotrexate
IC50 decreased from 150 g/mL in wild type and the un-
induced samples to 19.8 g/ml in the strain expressing the
sgRNA that targets the 5′ UTR, and to 75 g/ml in the
strain in which the sgRNA targets the dfrA promoter (Fig-
ure 3 and Supplementary Figure S5).
We then used CRISPRi to target the essential genes
wag31 (DivIVA), which is required for peptidoglycan syn-
thesis at the growing cell pole in mycobacteria (34,37), and
ftsZ, which is required for cell division (35). Using two dif-
ferent sgRNA constructs targeting the 5′ end of the wag31
coding sequence, we again obtained 80–90% reduction in
gene-specific RNA in strains in which either construct was
induced (Figure 4). Consistent with the severe growth de-
fect seen with genetic depletion of wag31 in M. smegmatis
(34), we observed nearly complete inhibition of growth in
both M. tuberculosis strains expressing sgRNAs targeting
wag31, starting at 24–48h following induction of these sgR-
NAs. For ftsZ, we obtained approximately 90% depletion
with both sgRNAs in the induced strains and saw a severe
growth phenotype, with essentially no growth following in-
duction of the sgRNA in either strain (Figure 4).
Depletion of ftsZ or wag31 in M. smegmatis has been
shown to cause changes in cell morphology (34,37,38).
These include elongation of ftsZ-depleted cells and asym-
metric polar bulging, followed by rounding and eventual ly-
sis, ofwag31-depleted cells.We therefore examined themor-
phology ofM. tuberculosis cells inwhich thesemRNAswere
depleted by CRISPRi. Depletion of ftsZ resulted in marked
elongation of cells at 24–48 h of sgRNA induction, consis-
tent with the phenotype observed with genetic depletion of
ftsZ inM. smegmatis (35).We also observed very large, mul-
tiply branched cells (Figure 5), indicating both failure of cell
division and aberrant initiation of peptidoglycan synthesis.
This novel phenotype suggests a critical role for ftsZ both
in the localized peptidoglycan synthesis required to form
the septum, and for localization of cell wall synthesis at the
new cell pole following cytokinesis. Depletion ofwag31 also
showed clear morphologic phenotypes. We observed initial
shortening of cells starting at 48h, followed by rounding and
asymmetric bulging of cells after 72–96 h of depletion (Fig-
ure 5). This phenotype indicates that in M. tuberculosis, as
inM. smegmatis, Wag31 is essential for polar, or more pre-
cisely sub-polar, cell wall synthesis (34,37).
Titration of CRISPRi
In testing the ability of CRISPRi to block expression of
essential genes, we used 200 ng/ml of aTc to achieve and
maintain maximal induction of dcas9 and the sgRNA. In
some situations, however, it may be desirable to achieve
more limited inhibition of gene expression.We therefore ex-
amined expression of ftsZ in M. tuberculosis cells express-
ing dcas9 and an ftsZ-specific sgRNA that were treated
with a range of aTc concentrations. We observed a clear
dose-response between the aTc concentration in the culture
and both the extent of dcas9 expression, and the extent to
which ftsZ mRNA was depleted (Figure 6). No effect was
observed at the lowest concentration (6.25 ng/ml) but at
higher aTc concentrations we saw a progressive increase in
dcas9 expression at both 24 and 48 h, which correlated with
greater ftsZmRNA depletion. This result indicates that it is
possible to titrate the extent of inhibition of gene expression
to achieve a level that is optimal for experiments that may
requiremoderate versusmore potent knockdown of specific
gene expression.
Off-target effects of CRISPRi inM. tuberculosis
A major challenge in the use of CRISPR nuclease technol-
ogy in eukaryotes has been the potential for off-target ef-
fects, i.e. cleavage at sites other than the one for which the
sgRNA was designed. Several approaches to identify and
minimize these effects have been investigated including tar-
geted approaches to detect predicted off-target sites and un-
biased genome-wide methods (Reviewed in (39)). Though
particularly problematic for gene deletion and gene editing,
off-target effects on gene expression could also affect inter-
pretation of target gene function in CRISPRi experiments.
We therefore attempted to investigate whether signifi-
cant off-target effects were observed in strains where we
had achieved effective inhibition of expression of the tar-
get gene. Current unbiased genome-wide methods to iden-
tify off-target effects of CRISPR gene editing require cleav-
age of genomic DNA by enzymatically active Cas9, and
tagging or marking of cleaved sites to allow enrichment
and sequencing of these sites (reviewed in (39)). There is
no established method for analysis of off-target effects of
CRISPRi of essential genes, because inhibition of expres-
sion of an essential gene will affect expression ofmany other
genes. We therefore undertook a targeted approach based
on the sequence-dependence of sgRNA gene targeting and
observations that off-target cleavage by Cas9 can occur at
sites with as many as five to six mismatches compared to
the protospacer sequence in the target gene (39). To do
this, we searched for sequences throughout the M. tuber-
culosis genome that were similar to the 20-base sequence
in the target gene that is targeted by each sgRNA. Us-
ing the search pattern function of the Tuberculist website
(http://genolist.pasteur.fr/Tuberculist), we searched the M.
tuberculosisH37Rv genome sequence for exact matches and
for sequences that differed by up to five bases from the 20
bases of the protospacer sequence the plus the adjacent 3-
base PAM sequence in the target gene (Supplementary Ta-
ble S1).
For the 16 sgRNAs that showed strong gene-specific in-
hibition in M. tuberculosis, four target sequences had no
matches in theM. tuberculosis genome that differed by five
or fewer bases from the PAM plus 20 nucleotide target gene
sequence. For five sgRNAswe found sequences that differed
by four bases, two of which had an adjacent PAM, and for
one sgRNAwe found a sequence that differed by two bases,
but which lacked a PAM. For nine sgRNAs, we identified
sites that differed by 5 nts from the target sequence, of which
three had an adjacent PAM sequence. We measured expres-
sion of all off-target genes containing a sequence that dif-
fered by 2 or 4 nts from the target sequence regardless of
whether there was an adjacent PAM. We also measured ex-
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Figure 4. CRISPRi of wag31 and ftsZ inM. tuberculosis. (A, D, G, J) Expression of dcas9 with and without induction of dcas9 and the sgRNA indicated.
(B, E, H, K) Expression of wag31 or ftsZ with and without induction of dcas9 and the sgRNA indicated. (C, F, I, L) Growth curves of culture with and
without induction of dcas9 and the sgRNA indicated. The significance of the difference in gene-specific RNAbetween samples from induced and uninduced
cultures is indicated by asterisks above the bar for the induced sample (*P < 0.01; **P < 0.001; ***P < 0.0001).
pression of the three genes that contained a sequence that
differed by 5 nt and that had an adjacent PAM. No signifi-
cantRNAdepletionwas observed for any of these off-target
genes (Supplementary Figure S6).
Based on its mechanism of action we anticipated that
CRISPRi targeting a gene in a multicistronic operon would
have polar effects on genes that were 3′ of the target gene
in the same operon. To address this experimentally, we de-
signed four sgRNAs to target pknA, a gene in the same
operon as, and immediately 5′ of pknB. Induction of two
of these constructs resulted in decreased pknA expression,
comparable to the decrease observed with other genes
shown above (Supplementary Figure S7). As expected, sim-
ilar decreases in pknB expression were seen in these strains,
indicating that targeting dCas9 to pknA had a polar effect
on the downstream gene pknB. Growth defects similar to
those seen with CRISPRi targeting of pknB were also seen.
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Figure 5. Morphology of cells in which ftsZ or wag31 have been depleted.
(A–C) Phase contrast microscopy M. tuberculosis cells containing vec-
tors for expression of dcas9 and the ftsZ+25 sgRNA, without aTc (A) or
with addition of aTc to 200 ng/ml (B and C). In each case photographs
were taken at 48 h. Panel (C) shows selected images of large, multiply
branched cells. (D) Measurement of cell size at 48h of CRISPRi with
ftsZ+25 sgRNA. (E and F) Phase contrast microscopy M. tuberculosis
cells containing vectors for expression of dcas9 and the wag31+26 sgRNA,
without aTc addition (E) or with aTc addition to 200 ng/ml (F). Pictures in
both panels were taken after 96h incubation. The significance of the differ-
ence in cell length andwidth between samples from induced and uninduced
cultures is indicated by asterisks above the bar for the induced sample (*P
< 0.01; **P < 0.001; ***P < 0.0001; ****P < 0.00001).
DISCUSSION
In this work, we describe an efficient CRISPR-based sys-
tem for specific inhibition of gene expression inM. tubercu-
losis. Using this approach we consistently achieved >80%
decreased expression of several essential genes, sufficient to
demonstrate growth phenotypes, altered drug susceptibil-
ity and morphologic phenotypes. Our ability to rapidly an-
alyze gene depletion phenotypes of each of the six essen-
tialM. tuberculosis genes that we targeted demonstrates the
power of this approach. Though many of these genes have
been partially characterized, much of the prior work has
been done in the rapid-growing non-pathogenM. smegma-
tis (18,34,35) because of the difficulties of achieving mRNA
or protein depletion in M. tuberculosis using previously
available tools.
In each experiment, we obtained induction of dcas9 inM.
tuberculosis at 24 and 48h, ranging from approximately 20-
fold to 65-fold above the uninduced level. In the pknB ex-
periment where expression was monitored from 8–96h we
saw a progressive decline in dcas9 expression, despite a sec-
ond addition of aTc at 48 h. The reason for the decline in
dcas9 expression is not known, but may reflect generalized
decreased gene expression at later growth stages resulting
from growth inhibition. Despite this, we saw persistent inhi-
bition of expression of pknB RNA and PknB protein (Fig-
ure 2). We also saw effects on growth and morphology at
4–6 days following induction of dcas9 and sgRNAs target-
ing several other essential genes (Figures 3–5), in each case
with addition of aTc every 48 h.
Though we focused on essential genes of at least partially
known function, our ability to achieve sustained inhibition
of gene expression in M. tuberculosis allowed us to iden-
tify a novel phenotype in ftsZ-depleted cells. Whereas a ge-
netic depletion strategy inM. smegmatis previously demon-
strated elongated filamentous cells (18), we observed not
only elongated cells but also very large cells with multiple
branches as early as 48 h of CRISPRi-mediated inhibition
of ftsZ in M. tuberculosis. A previous study demonstrated
that a small proportion ofM. tuberculosis cells grown in ac-
tivated macrophages, in which ftsZ was found not to be lo-
calized to the mid-cell, showed lateral budding that would
likely lead to branching over time (40). Our findings to-
gether with this published result suggest that ftsZ plays a
critical role not only in formation of the divisome, but also
in localizing new cell wall synthesis to the septum and to
the new cell pole after cell division. This interpretation is
consistent with several reports that have shown physical or
functional interactions of mycobacterial FtsZ with proteins
involved in cell wall synthesis (41–44).
The CRISPRi system described here has a number of fea-
tures that will make it extremely useful for the analysis of
essential gene function inM. tuberculosis. These include (i)
simple, unidirectional cloning of sequences homologous to
the target gene into an E. coli-mycobacterial shuttle vec-
tor, (ii) aTc-induced expression of codon-optimized dcas9 at
levels that do not inhibit growth but that result in sustained,
physiologically relevant inhibition of target gene expression
when expressed with a gene-specific sgRNA, (iii) the abil-
ity to design sgRNAs containing target gene sequences that
differ sufficiently from sequences elsewhere in the M. tu-
berculosis genome to minimize the likelihood of off-target
effects, (iv) the ability to compare CRISPRi-inhibited ex-
pression to native levels of expression from the chromoso-
mal gene, in contrast to genetic depletion strains where ex-
pression from an inducible promoter often differs markedly
from native levels of expression and (v) no disruption of
the chromosomal locus or the native gene, as is required for
protein degradation tag strategies. These advantages should
make CRISPRi a preferred approach for investigating non-
essential genes as well essential genes.
Despite these advantages, there is at least one important
limitation to this approach, the polar effect on expression
of genes that are 3′ of, and in the same operon as, the tar-
get gene. Though in some cases, e.g. where the function of
an operon is being investigated, this may be acceptable, in
many situations it is desirable to be able to investigate the
function of a single gene. In many cases, polar effects from
CRISPRi of genes 3′ of the target gene in an operon could
be addressed by heterologous expression of the downstream
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Figure 6. Titration of inducer for CRISPRi of ftsZ in M. tuberculosis. (A) Expression of dcas9 at 24 and 48 h of induction with different concentrations
of aTc. (B) Expression of ftsZ at 24 and 48 h of induction with different concentrations of aTc. The significance of the difference in gene-specific RNA in
samples from cultures treated with different concentrations of aTc compared to untreated samples at the same time point is indicated by asterisks above
the bar for the induced samples (*P < 0.01; **P < 0.001; ***P < 0.0001).
genes, however achieving appropriate levels of expression
can be difficult, as noted above.
Another potential limitation of CRISPRi is off-target ef-
fects. Though our testing of potential off-target sites for sev-
eral sgRNAs did not reveal gene-specific RNA depletion at
these sites, this result does not indicate that off-target effects
may not occur in some instances. Our approach of scan-
ning the genome for sequences similar to the candidate tar-
get sequence, however, should allow investigators to design
sgRNAs to avoid off-target effects in most cases by choos-
ing target sequences that are not similar (>5 mismatches)
to other sequences in the M. tuberculosis genome. If a tar-
get sequence in a gene of interest that is dissimilar to all
other M. tuberculosis sequences cannot be identified, veri-
fying that the off-target sequences lack an adjacent PAM
should preclude dCas9 binding and inhibition of gene ex-
pression at that site. In cases where off-target sequences
that have an intact PAM adjacent to a sequence with five
or fewer mismatches to the protospacer being targeted can-
not be avoided, these can be considered potential sites for
off-target inhibition of gene expression, which can be tested
experimentally.
In every case where we designed and tested two to four
sgRNAs, most constructs achieved highly effective (80–
90%) inhibition of gene expression. The reason for the lower
activity of the minority of constructs is not apparent. Each
sgRNA construct incorporated 20 bases of sequence ho-
mologous to a sequence in the target gene, and met known
criteria for effective sequence targeting, i.e. each sgRNA
was designed to bind to the non-template DNA strand, and
each selected target was immediately adjacent to a PAM se-
quence. It is possible that specific sequences are more ef-
ficient at displacing the template strand to allow binding
of the sgRNA to the non-template strand. A recent report
identified more effective gene targeting in eukaryotes when
the last 4 nts of the protospacer sequence were purines (45).
In our limited number of sgRNAs, this preference was not
apparent, e.g. the one protospacer sequence in which all
four 3′ nts were purines (pknB+8) achieved slightly less inhi-
bition than two others (pknB+51 and pknB+143) in which
3 of 4 nts were pyrimidines. We observed effective repres-
sion of gene expression with constructs that targeted the
promoter region, the 5′-UTR and the coding sequence, sug-
gesting that interference with either transcription initiation
or elongation can be effective, as described for E. coli (15).
Tools for the study ofM. tuberculosis, including more ef-
ficient gene deletion techniques, better inducible promoters
and new protein depletion systems have markedly improved
our ability to investigate this important human pathogen.
CRISPRi adds a powerful approach to this complement of
methods to investigate M. tuberculosis. In particular, this
simple and efficient method to inhibit the expression of es-
sential genes of unknown function has the potential both
to accelerate the investigation ofM. tuberculosis pathogen-
esis and to facilitate the development of novel drugs forM.
tuberculosis, e.g. by allowing the characterization of novel
drug targets and by identifying or verifying targets of novel
small molecule inhibitors identified in whole cell screens.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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